Literature DB >> 25547976

Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study.

Mike van der Have1, Lianne K P M Brakenhoff2, Sanne J H van Erp2, Ad A Kaptein3, Max Leenders1, Margreet Scharloo3, Roeland A Veenendaal2, Désirée M F M van der Heijde4, Andrea E van der Meulen-de Jong2, Daan W Hommes5, Herma H Fidder6.   

Abstract

BACKGROUND AND AIMS: Back and joint pain are the most common extraintestinal symptoms reported by patients with inflammatory bowel disease (IBD). We assessed the impact of back/joint pain, illness perceptions, and coping on quality of life (QOL) and work productivity in patients with IBD.
METHODS: Our cohort included 155 IBD patients with and 100 without arthropathy. Arthropathy was defined as daily back pain for ≥3 months and/or peripheral joint pain and/or joint swelling over the last year. At baseline and at 12 months, patients completed questionnaires on the extent of back/joint pain, IBD disease activity, illness perceptions, coping, QOL, and work productivity. The impact of back/joint pain, illness perceptions and coping on QOL and work productivity was determined, using linear mixed models.
RESULTS: In total, 204 IBD patients (72% Crohn's disease, 40% male, mean age 44 ± 14 years) completed questionnaires at both time points. At both time points, IBD patients with back/joint pain reported a significantly lower QOL and work productivity compared with IBD patients without back/joint pain. Predictors of low QOL were back/joint pain (β = -1.04, 95% confidence interval [CI] -1.40, -0.68), stronger beliefs about the illness consequences (β = -0.39, 95% CI -0.59, -0.18) and emotional impact of IBD (β = -0.47, 95% CI -0.66, -0.28), and the coping strategy 'decreasing activity' (β = -0.26, 95% CI -0.48, -0.03). Predictors of work productivity were back/joint pain (β = 0.22, 95% CI 0.07, 0.37) and illness consequences (β = 0.14, 95% CI 0.06, 0.22).
CONCLUSION: Back/joint pain, illness perceptions, and coping are significant predictors of QOL and work productivity, after controlling for disease activity.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arthralgia; Common Sense Model; coping; illness perceptions; inflammatory bowel disease; quality of life; work productivity

Mesh:

Year:  2014        PMID: 25547976     DOI: 10.1093/ecco-jcc/jju025

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  17 in total

1.  Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

2.  General Well-being and Coping Strategies in Adult Eosinophilic Esophagitis Patients.

Authors:  Willemijn E de Rooij; Floor Bennebroek Evertsz; Aaltje Lei; Albert J Bredenoord
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

3.  The Influence of the Inflammatory Bowel Diseases on the Perceived Stress and Quality of Life in a Sample of the South-Western Romanian Population.

Authors:  Denisa-Elena Popa; Mihail-Cristian Pîrlog; Dragoş-Ovidiu Alexandru; Dan-Ionuţ Gheonea
Journal:  Curr Health Sci J       Date:  2022-03-31

4.  Pilot Study of Functional Magnetic Resonance Imaging Responses to Somatic Pain Stimuli in Youth With Functional and Inflammatory Gastrointestinal Disease.

Authors:  Jeannie S Huang; Laura Terrones; Alan N Simmons; Walter Kaye; Irina Strigo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

5.  Illness Perceptions and Outcomes in Patients with Inflammatory Bowel Disease: Is Coping a Mediator?

Authors:  S J H van Erp; L K M P Brakenhoff; M Vollmann; D van der Heijde; R A Veenendaal; H H Fidder; D W Hommes; A A Kaptein; Andrea E van der Meulen-de Jong; M Scharloo
Journal:  Int J Behav Med       Date:  2017-04

6.  Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn's Disease Patients in Clinical Remission.

Authors:  Caterina Viganò; Roberta Calzolari; Paola Marianna Marinaccio; Cristina Bezzio; Federica Furfaro; Gabriella Ba; Giovanni Maconi
Journal:  Gastroenterol Res Pract       Date:  2015-12-28       Impact factor: 2.260

7.  Disease impact on the quality of life of children with inflammatory bowel disease.

Authors:  Giorgos Chouliaras; Daphne Margoni; Konstantina Dimakou; Smaragdi Fessatou; Ioanna Panayiotou; Eleftheria Roma-Giannikou
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

8.  The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review.

Authors:  F Pagnini; G Graffigna; E Volpato; C Bosio; E Previtali; S Leone; A Armuzzi
Journal:  BMC Gastroenterol       Date:  2021-07-14       Impact factor: 3.067

9.  Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.

Authors:  Jonas Zeitz; Melike Ak; Séverine Müller-Mottet; Sylvie Scharl; Luc Biedermann; Nicolas Fournier; Pascal Frei; Valerie Pittet; Michael Scharl; Michael Fried; Gerhard Rogler; Stephan Vavricka
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease.

Authors:  Lars-Petter Jelsness-Jørgensen; Bjørn Moum; Tore Grimstad; Jørgen Jahnsen; Randi Opheim; Ingrid Prytz Berset; Øistein Hovde; Roald Torp; Svein Oskar Frigstad; Gert Huppertz-Hauss; Tomm Bernklev
Journal:  Can J Gastroenterol Hepatol       Date:  2016-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.